Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2003

View Archived Issues

Microscience collaborates with NMRC to test anthrax vaccine

Long-term safety and efficacy of SPM-927 in epilepsy

Corixa reports development status of two MPL-containing vaccines

deCODE isolates new obesity genes

Topline results from pivotal Metformin GR study

Lexapro as effective as Zoloft in recent study

T-62 enters phase I testing for neuropathic pain

Phase I trial commences for CNTO-95

Avanir and Peregrine execute license agreement for antibody

Praecis collaborates with NCI on PPI-2458

R-112 safe and well tolerated in phase I study

Rifaximin NDA amendment considered complete response

Inhibition of factor 5A1 reduces apoptosis caused by TNF-alpha

Dosing complete in phase I Oxycyte study

Xechem to acquire Ceptor

Phase II trial evaluates RG-1068 for refractory schizophrenia

Fujisawa launches pediatric Protopic in Japan

Good safety profile observed for a West Nile virus vaccine in monkeys

Phase I clinical results reported for MalariVax

Compositions of lafutidine for IBD

Pyrimidine-based compounds that inhibit elastase described by Ono

Sumitomo patents new series of DPP-IV inhibitors

Macrolide antibacterial agents identified at Abbott

BMS prepares new anti-HIV series

Modulators of NK cell activity and their application described in recent patent

ST-1899: pharmacological profile indicates promise in schizophrenia

Antibacterial activity, pharmacokinetics and toxicity of HARP antibacterial compounds

Potential use of AQ-13 for malaria unresponsive to current aminoquinolines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...